$268.12M Market Cap.
LUNG Market Cap. (MRY)
LUNG Shares Outstanding (MRY)
LUNG Assets (MRY)
Total Assets
$162.85M
Total Liabilities
$77.04M
Total Investments
$30.58M
LUNG Income (MRY)
Revenue
$83.79M
Net Income
-$56.39M
Operating Expense
$119.70M
LUNG Cash Flow (MRY)
CF Operations
-$31.54M
CF Investing
$17.48M
CF Financing
$1.36M
LUNG Dividends (MRY)
Period | Dividends | Yield % | Growth % | Payout Ratio | Coverage Ratio |
|---|---|---|---|---|---|
2024 | $0 | 0% | 0% | 0% | - |
2023 | $0 | 0% | 0% | 0% | - |
2022 | $0 | 0% | 0% | 0% | - |
2021 | $0 | 0% | 0% | 0% | - |
2020 | $0 | 0% | - | 0% | - |
LUNG Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $162,850,000 (-8.40%) | $177,781,000 (-8.21%) | $193,676,000 (-17.65%) | $235,173,000 (-10.82%) |
Assets Current | $136,248,000 (-9.42%) | $150,422,000 (-10.97%) | $168,953,000 (-18.77%) | $208,002,000 (-16.80%) |
Assets Non-Current | $26,602,000 (-2.77%) | $27,359,000 (10.66%) | $24,723,000 (-9.01%) | $27,171,000 (98.05%) |
Goodwill & Intangible Assets | $2,333,000 (-1.31%) | $2,364,000 (-4.95%) | $2,487,000 (-4.71%) | $2,610,000 (-4.50%) |
Shareholders Equity | $85,809,000 (-27.47%) | $118,315,000 (-23.18%) | $154,007,000 (-20.30%) | $193,239,000 (-14.55%) |
Property Plant & Equipment Net | $21,452,000 (188.57%) | $7,434,000 (-29.20%) | $10,500,000 (-18.54%) | $12,889,000 (23.34%) |
Cash & Equivalents | $71,162,000 (-15.06%) | $83,784,000 (-17.83%) | $101,967,000 (-31.43%) | $148,711,000 (-35.84%) |
Accumulated Other Comprehensive Income | $2,113,000 (-19.96%) | $2,640,000 (67.62%) | $1,575,000 (-8.00%) | $1,712,000 (1.60%) |
Deferred Revenue | $135,000 (29.81%) | $104,000 (-13.33%) | $120,000 (-26.38%) | $163,000 (129.58%) |
Total Investments | $30,577,000 (-36.22%) | $47,945,000 (5.78%) | $45,326,000 (6.64%) | $42,502,000 (0%) |
Investments Current | $30,577,000 (-8.87%) | $33,555,000 (-14.84%) | $39,402,000 (24.84%) | $31,561,000 (0%) |
Investments Non-Current | $0 (0%) | $14,390,000 (142.91%) | $5,924,000 (-45.86%) | $10,941,000 (0%) |
Inventory | $18,596,000 (-3.76%) | $19,323,000 (-2.64%) | $19,847,000 (21.87%) | $16,285,000 (51.62%) |
Trade & Non-Trade Receivables | $13,120,000 (8.38%) | $12,105,000 (39.51%) | $8,677,000 (32.23%) | $6,562,000 (55.20%) |
Trade & Non-Trade Payables | $3,827,000 (155.64%) | $1,497,000 (-14.85%) | $1,758,000 (11.13%) | $1,582,000 (7.47%) |
Accumulated Retained Earnings (Deficit) | -$467,555,000 (-13.72%) | -$411,161,000 (-17.37%) | -$350,318,000 (-20.22%) | -$291,395,000 (-20.05%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $136,000 (-34.30%) | $207,000 (83.19%) | $113,000 (-38.59%) | $184,000 (17.95%) |
Total Debt | $56,471,000 (36.32%) | $41,424,000 (69.76%) | $24,402,000 (-7.78%) | $26,460,000 (-2.81%) |
Debt Current | $3,954,000 (-24.38%) | $5,229,000 (57.55%) | $3,319,000 (44.81%) | $2,292,000 (2.41%) |
Debt Non-Current | $52,517,000 (45.09%) | $36,195,000 (71.68%) | $21,083,000 (-12.76%) | $24,168,000 (-3.27%) |
Total Liabilities | $77,041,000 (29.55%) | $59,466,000 (49.91%) | $39,669,000 (-5.40%) | $41,934,000 (11.60%) |
Liabilities Current | $24,437,000 (5.53%) | $23,157,000 (25.23%) | $18,492,000 (5.37%) | $17,550,000 (40.11%) |
Liabilities Non-Current | $52,604,000 (44.88%) | $36,309,000 (71.45%) | $21,177,000 (-13.15%) | $24,384,000 (-2.65%) |
LUNG Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $83,789,000 (22.01%) | $68,675,000 (27.98%) | $53,662,000 (10.84%) | $48,416,000 (47.91%) |
Cost of Revenue | $21,788,000 (21.56%) | $17,923,000 (29.91%) | $13,797,000 (7.91%) | $12,786,000 (10.88%) |
Selling General & Administrative Expense | $102,135,000 (7.96%) | $94,607,000 (13.84%) | $83,105,000 (18.94%) | $69,871,000 (51.65%) |
Research & Development Expense | $17,570,000 (-2.82%) | $18,080,000 (17.43%) | $15,397,000 (17.87%) | $13,063,000 (75.11%) |
Operating Expenses | $119,705,000 (6.23%) | $112,687,000 (14.40%) | $98,502,000 (18.77%) | $82,934,000 (54.92%) |
Interest Expense | $3,507,000 (8.51%) | $3,232,000 (203.19%) | $1,066,000 (28.59%) | $829,000 (-73.94%) |
Income Tax Expense | $500,000 (-12.43%) | $571,000 (61.76%) | $353,000 (2.92%) | $343,000 (61.03%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$56,394,000 (7.31%) | -$60,843,000 (-3.26%) | -$58,923,000 (-21.09%) | -$48,661,000 (-50.98%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$56,394,000 (7.31%) | -$60,843,000 (-3.26%) | -$58,923,000 (-21.09%) | -$48,661,000 (-50.98%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$56,394,000 (7.31%) | -$60,843,000 (-3.26%) | -$58,923,000 (-21.09%) | -$48,661,000 (-50.98%) |
Weighted Average Shares | $39,111,073 (2.99%) | $37,974,567 (2.37%) | $37,096,541 (2.68%) | $36,129,409 (254.74%) |
Weighted Average Shares Diluted | $39,111,073 (2.99%) | $37,974,567 (2.37%) | $37,096,541 (2.68%) | $36,129,409 (254.74%) |
Earning Before Interest & Taxes (EBIT) | -$52,387,000 (8.16%) | -$57,040,000 (0.81%) | -$57,504,000 (-21.09%) | -$47,489,000 (-64.68%) |
Gross Profit | $62,001,000 (22.16%) | $50,752,000 (27.31%) | $39,865,000 (11.89%) | $35,630,000 (68.05%) |
Operating Income | -$57,704,000 (6.83%) | -$61,935,000 (-5.62%) | -$58,637,000 (-23.96%) | -$47,304,000 (-46.31%) |
LUNG Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | $17,476,000 (970.75%) | -$2,007,000 (52.50%) | -$4,225,000 (90.87%) | -$46,255,000 (-464.38%) |
Net Cash Flow from Financing | $1,363,000 (-93.63%) | $21,400,000 (784.66%) | $2,419,000 (-45.71%) | $4,456,000 (-98.10%) |
Net Cash Flow from Operations | -$31,537,000 (16.15%) | -$37,610,000 (16.58%) | -$45,083,000 (-8.93%) | -$41,388,000 (-35.11%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$12,622,000 (30.58%) | -$18,183,000 (61.10%) | -$46,744,000 (43.74%) | -$83,081,000 (-138.28%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $18,923,000 (1676.92%) | -$1,200,000 (58.72%) | -$2,907,000 (93.17%) | -$42,584,000 (-413.00%) |
Capital Expenditure | -$1,447,000 (-79.31%) | -$807,000 (38.77%) | -$1,318,000 (64.10%) | -$3,671,000 (-302.96%) |
Issuance (Repayment) of Debt Securities | -$95,000 (-100.48%) | $19,906,000 (14318.57%) | -$140,000 (-241.46%) | -$41,000 (-100.12%) |
Issuance (Purchase) of Equity Shares | $1,458,000 (-2.41%) | $1,494,000 (-41.62%) | $2,559,000 (-43.10%) | $4,497,000 (-97.80%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $76,000 (123.53%) | $34,000 (-76.55%) | $145,000 (36.79%) | $106,000 (-20.30%) |
Share Based Compensation | $22,955,000 (3.86%) | $22,101,000 (34.39%) | $16,445,000 (56.17%) | $10,530,000 (229.37%) |
Depreciation Amortization & Accretion | $3,337,000 (-21.19%) | $4,234,000 (5.56%) | $4,011,000 (24.30%) | $3,227,000 (65.49%) |
LUNG Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | 74.00% (0.14%) | 73.90% (-0.54%) | 74.30% (0.95%) | 73.60% (13.58%) |
Profit Margin | -67.30% (24.04%) | -88.60% (19.31%) | -109.80% (-9.25%) | -100.50% (-2.03%) |
EBITDA Margin | -58.50% (23.93%) | -76.90% (22.87%) | -99.70% (-9.08%) | -91.40% (-11.33%) |
Return on Average Equity (ROAE) | -57.60% (-23.61%) | -46.60% (-32.76%) | -35.10% (-48.10%) | -23.70% (85.75%) |
Return on Average Assets (ROAA) | -33.80% (-5.30%) | -32.10% (-13.43%) | -28.30% (-43.65%) | -19.70% (2.96%) |
Return on Sales (ROS) | -62.50% (24.79%) | -83.10% (22.48%) | -107.20% (-9.28%) | -98.10% (-11.35%) |
Return on Invested Capital (ROIC) | -40.50% (20.90%) | -51.20% (15.65%) | -60.70% (14.87%) | -71.30% (-8.03%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -4.71 (40.83%) | -7.97 (-50.30%) | -5.3 (77.68%) | -23.76 (-8.76%) |
Price to Sales Ratio (P/S) | 3.17 (-55.05%) | 7.05 (20.97%) | 5.83 (-75.65%) | 23.93 (11.44%) |
Price to Book Ratio (P/B) | 3.13 (-24.30%) | 4.13 (101.56%) | 2.05 (-66.50%) | 6.11 (-43.84%) |
Debt to Equity Ratio (D/E) | 0.9 (78.53%) | 0.5 (94.96%) | 0.26 (18.89%) | 0.22 (30.72%) |
Earnings Per Share (EPS) | -1.44 (10.00%) | -1.6 (-0.63%) | -1.59 (-17.78%) | -1.35 (57.28%) |
Sales Per Share (SPS) | 2.14 (18.47%) | 1.81 (24.95%) | 1.45 (7.99%) | 1.34 (-58.31%) |
Free Cash Flow Per Share (FCFPS) | -0.84 (16.70%) | -1.01 (19.10%) | -1.25 (-0.32%) | -1.25 (59.74%) |
Book Value Per Share (BVPS) | 2.19 (-29.59%) | 3.12 (-24.95%) | 4.15 (-22.38%) | 5.35 (-75.91%) |
Tangible Assets Book Value Per Share (TABVPS) | 4.1 (-11.15%) | 4.62 (-10.38%) | 5.15 (-19.93%) | 6.44 (-74.88%) |
Enterprise Value Over EBIT (EV/EBIT) | -5 (37.50%) | -8 (-100.00%) | -4 (80.95%) | -21 (75.58%) |
Enterprise Value Over EBITDA (EV/EBITDA) | -5.31 (35.64%) | -8.25 (-93.59%) | -4.26 (81.51%) | -23.04 (75.01%) |
Asset Turnover | 0.5 (38.29%) | 0.36 (40.70%) | 0.26 (31.63%) | 0.2 (-4.85%) |
Current Ratio | 5.58 (-14.18%) | 6.5 (-28.90%) | 9.14 (-22.91%) | 11.85 (-40.62%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$32,984,000 (14.14%) | -$38,417,000 (17.21%) | -$46,401,000 (-2.98%) | -$45,059,000 (-42.84%) |
Enterprise Value (EV) | $260,361,698 (-40.21%) | $435,465,441 (91.08%) | $227,898,548 (-77.65%) | $1,019,887,045 (-58.86%) |
Earnings Before Tax (EBT) | -$55,894,000 (7.26%) | -$60,272,000 (-2.91%) | -$58,570,000 (-21.22%) | -$48,318,000 (-50.91%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$49,050,000 (7.11%) | -$52,806,000 (1.28%) | -$53,493,000 (-20.86%) | -$44,262,000 (-64.62%) |
Invested Capital | $121,389,000 (10.45%) | $109,900,000 (15.52%) | $95,132,000 (2.55%) | $92,762,000 (111.39%) |
Working Capital | $111,811,000 (-12.14%) | $127,265,000 (-15.42%) | $150,461,000 (-21.00%) | $190,452,000 (-19.80%) |
Tangible Asset Value | $160,517,000 (-8.49%) | $175,417,000 (-8.25%) | $191,189,000 (-17.79%) | $232,563,000 (-10.89%) |
Market Capitalization | $268,122,698 (-45.11%) | $488,428,441 (54.88%) | $315,359,548 (-73.31%) | $1,181,417,045 (-52.01%) |
Average Equity | $97,854,000 (-25.01%) | $130,486,000 (-22.31%) | $167,954,000 (-18.33%) | $205,650,500 (961.26%) |
Average Assets | $166,865,500 (-11.85%) | $189,295,500 (-8.93%) | $207,864,250 (-15.69%) | $246,550,250 (55.43%) |
Invested Capital Average | $129,498,000 (16.18%) | $111,465,500 (17.72%) | $94,690,000 (42.26%) | $66,560,250 (52.24%) |
Shares | 39,487,879 (3.08%) | 38,308,113 (2.40%) | 37,409,199 (1.55%) | 36,838,698 (3.28%) |
